Finnrick - Ensuring a Safer and More Transparent Supply Chain
Zhengzhou Lanyun

Zhengzhou Lanyun

Retatrutide

Finnrick tested 7 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Zhengzhou Lanyun between 7 Jan 2026 and 3 Mar 2026. Test scores average over 5, no score below 4, and at least 6 tests warrant a confident Finnrick Rating of C (Okay).

Finnrick Rating™
Zhengzhou Lanyun
Retatrutide
Tested 7 Samples
Last test 3 Mar 2026

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

Other Retatrutide tests from top-rated vendors:

All Retatrutide tests from Zhengzhou Lanyun

Samples are tested in commercial labs

Tests Count

7

Scores

AVG7.6MIN5.0MAX9.3

Last

3 Mar 2026

First

7 Jan 2026
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityEndotoxinsBatch IDContainerTested AtSent By
3 Mar 2026View9.010mg10.1mg+1.0%99.50%n/a01/02/2026(no data)Lab EPublic
26 Feb 2026View7.040mg41.4mg+3.5%95.87%n/aJul 15,2025No Label / Silver Crimp / Clear Red CapLab EPublic
26 Jan 2026View7.810mg9.7mg-3.0%99.80%n/a(no batch ID)No Label / Silver Crimp / Yellow CapLab GPublic
19 Jan 2026View5.010mg9.73mg-2.7%97.55%
below LOQ
(no batch ID)No Label / Silver Crimp / Yellow CapLab EPublic
15 Jan 2026View7.35mg5mg99.60%n/a(no batch ID)No Label / Silver Crimp / Blue CapLab GPublic
7 Jan 2026View7.830mg30.6mg+2.0%99.80%n/a(no batch ID)No Label / Silver Crimp / Blue CapLab GPublic
7 Jan 2026View9.310mg10.1mg+1.0%99.60%n/aNov 2, 2025No Label / Silver Crimp / Yellow CapLab GPublic